Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-04-019519
Filing Date
2004-02-11
Accepted
2004-02-11 14:53:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SC 13G dsc13ga.htm SC 13G/A 50061
  Complete submission text file 0001193125-04-019519.txt   51996
Mailing Address 485 UNDERHILL BLVD STE 205 SYOSSET NY 11791-3419
Business Address 485 UNDERHILL BLVD STE 205 SYOSSET NY 11791-3419
KNOTT DAVID M (Filed by) CIK: 0000808722 (see all company filings)

 

Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Subject) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-49245 | Film No.: 04585862
SIC: 2836 Biological Products, (No Diagnostic Substances)